During the past decade, Onkologische Praxis Oldenburg conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Onkologische Praxis Oldenburg" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials, followed by "iOMEDICO AG" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologische Praxis Oldenburg" #1 collaborator was "German Cancer Research Center" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Janssen Diagnostics, LLC" with 1 trials as a collaborator, "Janssen-Cilag International NV" with 1 trials as a collaborator and "Mundipharma Research GmbH & Co KG" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Onkologische Praxis Oldenburg" are "Multiple Myeloma" (4 trials), "Lymphoma" (2 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Onkologische Praxis Oldenburg" in a lesser frequency.

Most popular intervention types in "Onkologische Praxis Oldenburg" are "Drug" (10 trials), "Biological" (3 trials), "Radiation" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "filgrastim" (3 trials), "radiation therapy" (3 trials), "doxorubicin hydrochloride" (2 trials) and "etoposide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Onkologische Praxis Oldenburg" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Onkologische Praxis Oldenburg". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Onkologische Praxis Oldenburg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Onkologische Praxis Oldenburg, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".